Loading...
XSHG
600272
Market cap422mUSD
Oct 09, Last price  
15.65CNY
1D
0.97%
1Q
45.04%
Jan 2017
-18.74%
IPO
15.85%
Name

Shanghai Kai Kai Industry Co Ltd

Chart & performance

D1W1MN
XSHG:600272 chart
P/E
220.95
P/S
2.53
EPS
0.07
Div yield, %
0.28%
Shrs. gr., 5y
2.57%
Rev. gr., 5y
8.21%
Revenues
1.13b
+3.33%
693,945,460679,411,784711,292,188865,662,045866,897,808797,189,525818,017,338859,439,008882,798,198881,279,114906,058,548962,101,571877,569,053870,398,325761,821,632669,830,444894,171,856925,070,3761,093,917,0171,130,331,272
Net income
13m
-63.03%
08,737,18356,256,91239,503,23426,703,78038,578,67760,837,30425,446,76336,345,31419,847,01621,292,23338,730,49335,234,31921,976,31113,674,80521,717,15839,928,20139,300,11434,999,09412,937,529
CFO
150m
P
55,469,35423,326,2753,590,469046,777,788023,232,65114,391,62327,550,97112,170,09611,270,51572,647,25432,074,93720,728,06281,659,66826,714,57079,342,921578,427-61,571,315149,810,191
Dividend
Jul 07, 20260.015 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shanghai Kai Kai Industry Company Limited, established in 1993 and based in Shanghai, China, is involved in a range of activities within the Chinese market. The company's operations include the manufacturing, wholesale distribution, and direct retail of various goods, specifically apparel such as shirts and sweaters, as well as a selection of pharmaceuticals, encompassing both traditional Chinese and Western medicines.

Key people

Guangjing Liu
General Manager, Director · since 2018
Heng Chen
Chief Financial Officer, Deputy General Manager, Director · since 2025
Yanhua Zhang
Secretary of the Board · since 2018
Lingling Gong
Director · since 2025
Zhiyong Jiao
Director · since 2023
Xianghua Zhang
Vice Chairman of the Board · since 2011
Yun Zhu
Director · since 2021
Qianyun Zhuang
Chairman of the Board · since 2018
Yujie Xia
Independent Director · since 2022
Independent Director · since 2025
IPO date
Feb 28, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT